Email alerts
Advanced Search
  • Sep 23, 2010
    Medtronic Initiates Global Commitment to Address Burden of Non-Communicable Disease
    Announced at Clinton Global Initiative, an initial $1 million in grants are part of an overall strategic effort to reduce the burden of chronic disease

    MINNEAPOLIS, Sep 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. today announced at the Clinton Global Initiative a $1 million commitment to the NCD Alliance. The grants are made in preparation for...

  • Sep 20, 2010
    Medtronic Receives FDA Approval of Integrity(R) Coronary Stent
    Superior Deliverability Distinguishes New Medical Device Based on Engineering Advance of Continuous Sinusoid Technology

    MINNEAPOLIS, Sep 20, 2010 (BUSINESS WIRE) -- Delivering another innovation for interventional cardiology, Medtronic, Inc. (NYSE: MDT), announced today the U.S. Food and Drug Administration (FDA)...

  • Sep 20, 2010
    Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
    Consistent Results in More Than 3,600 Patients from Complex Daily Practice of Interventional Cardiology Strengthen Evidence on Implantable Heart Device

    WASHINGTON, Sep 22, 2010 (BUSINESS WIRE) -- Coronary artery disease, a leading cause of death and poor quality of life worldwide, runs the gamut from simple to complex, which complicates the daily...

  • Sep 17, 2010
    Newly Published Data Show Occipital Nerve Stimulation May Be a Promising New Therapy for Chronic Migraine
    Initial Results Suggest ONS Warrants Further Study for Control of Chronic Migraine

    MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise...

  • Sep 17, 2010
    Medtronic Showcases Cardiovascular Devices at TCT 2010
    Interventional Cardiology Meeting Features New Data on Resolute(R) Drug-Eluting Stent, IN.PACT(TM) Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve

    MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease,Medtronic, Inc. (NYSE: MDT), today...

Show 5102550100 per page